Trending...
- Extending The Lifespan Of Your Commercial Air Conditioner
- Ubleu Crypto Group Achieves FinCEN Registration and Colorado Incorporation, Accelerating U.S. Market Entry
- Dr. Sanju P. Jose Highlights Expertise in Periodontics and Implant Dentistry
SYDNEY - AussieJournal -- Hospital Products Australia (HPA) has announced the Australian launch of the AirICU Max+, a breakthrough mesh nebuliser that delivers aerosol medication with unmatched precision, safety, and efficiency across all stages of respiratory support. Recently approved by the TGA and available exclusively through HPA, the AirICU Max+ is redefining how respiratory therapy is delivered in critical environments from intensive care units to emergency departments.
The Future of Nebulisation: AiMesh® at the Core
At the heart of the AirICU Max+ lies AiMesh®, an advanced vibrating mesh system that fuses AI-driven algorithms with proprietary materials to consistently produce aerosol particles under 5 μm, the optimal size for deep lung delivery. This precise targeting improves therapeutic outcomes, speeds symptom relief, and reduces hospital stays.
Clinical evidence shows AiMesh® technology can deliver measurable improvements in lung function, reduced admissions and shorter emergency department stays, and faster onset of medication effectiveness.
More on Aussie Journal
Breath-Synchronised Intelligence
With its dual modes, continuous delivery and inhalation-triggered induction, the AirICU Max+ ensures medication is only delivered when the patient breathes in. This intelligent breath-synchronised approach maximises drug delivery efficiency, minimises medication waste, enhances patient comfort, and supports infection control with closed-circuit compatibility and integrated filtration options.
Engineered for Any Critical Care Setting
Compact, whisper quiet, and lightweight, the AirICU Max+ integrates seamlessly into clinical workflows across ICUs, EDs, NICUs, HDUs, intra hospital transport, and bedside care. Dual power options, USB and battery, give clinicians complete flexibility for both stationary and mobile treatment.
Designed for versatility, it is compatible with a broad spectrum of medications, from bronchodilators to antibiotics, and supports both reusable and single use components to meet the highest standards of infection control and cost efficiency.
"The introduction of the AirICU Max+ to Australia represents a pivotal step forward in precision aerosol therapy. This launch underscores HPA's unwavering commitment to equipping healthcare teams with intelligent, safer, and more effective respiratory solutions. The AirICU Max+ is not merely a nebuliser, it is a next generation clinical platform, purposely built to elevate the standard of care in the most demanding critical care environments," said Shawn Wigham, Managing Director of HPA.
More on Aussie Journal
Edward Hua, CEO of Feellife affirmed the collaboration's significance, stating: "At Feellife, our mission is to lead the transformation of respiratory care through innovation and science. Partnering with HPA to deliver the AirICU Max+ to Australian healthcare teams is a milestone that will help shape the future of patient outcomes nationwide."
Comprehensive Support for Adoption
HPA is backing the launch with a complete onboarding package, including hands-on training sessions for clinical teams, digital tutorials and quick reference guides for fast integration, and ongoing technical service and support to ensure long-term reliability.
For more information, visit https://www.hpaust.com
The Future of Nebulisation: AiMesh® at the Core
At the heart of the AirICU Max+ lies AiMesh®, an advanced vibrating mesh system that fuses AI-driven algorithms with proprietary materials to consistently produce aerosol particles under 5 μm, the optimal size for deep lung delivery. This precise targeting improves therapeutic outcomes, speeds symptom relief, and reduces hospital stays.
Clinical evidence shows AiMesh® technology can deliver measurable improvements in lung function, reduced admissions and shorter emergency department stays, and faster onset of medication effectiveness.
More on Aussie Journal
- RUNWAY Milestones 1995-2025 Global Influence
- Melbourne Properties Get 24/7 Protection with Victoria Hygiene Services' Next-Gen Technology
- Buying Any Cars Expands Service Area Across SE Queensland and Northern NSW
- Recent Superannuation Changes To Understand
- Google AI Mode Tells You Dr. Bob Akmens & BASports.com is the GOAT in College Football Handicapping
Breath-Synchronised Intelligence
With its dual modes, continuous delivery and inhalation-triggered induction, the AirICU Max+ ensures medication is only delivered when the patient breathes in. This intelligent breath-synchronised approach maximises drug delivery efficiency, minimises medication waste, enhances patient comfort, and supports infection control with closed-circuit compatibility and integrated filtration options.
Engineered for Any Critical Care Setting
Compact, whisper quiet, and lightweight, the AirICU Max+ integrates seamlessly into clinical workflows across ICUs, EDs, NICUs, HDUs, intra hospital transport, and bedside care. Dual power options, USB and battery, give clinicians complete flexibility for both stationary and mobile treatment.
Designed for versatility, it is compatible with a broad spectrum of medications, from bronchodilators to antibiotics, and supports both reusable and single use components to meet the highest standards of infection control and cost efficiency.
"The introduction of the AirICU Max+ to Australia represents a pivotal step forward in precision aerosol therapy. This launch underscores HPA's unwavering commitment to equipping healthcare teams with intelligent, safer, and more effective respiratory solutions. The AirICU Max+ is not merely a nebuliser, it is a next generation clinical platform, purposely built to elevate the standard of care in the most demanding critical care environments," said Shawn Wigham, Managing Director of HPA.
More on Aussie Journal
- Google AI Mode says Dr. Bob Akmens and BASports.com are the GOAT in Sports Handicapping
- EZSMO Launches Premium Aged Reddit Accounts and Marketing Solutions with 15-Day Ban-Free Guarantee
- Sultry Jazz Singer Kathy Sanborn Releases Steamy Romance Language
- Vancouver Community College Forms Strategic Partnership with PebblePad
- ATO Overdue Tax Return Penalty in 2025: What Aussie Taxpayers Must Know
Edward Hua, CEO of Feellife affirmed the collaboration's significance, stating: "At Feellife, our mission is to lead the transformation of respiratory care through innovation and science. Partnering with HPA to deliver the AirICU Max+ to Australian healthcare teams is a milestone that will help shape the future of patient outcomes nationwide."
Comprehensive Support for Adoption
HPA is backing the launch with a complete onboarding package, including hands-on training sessions for clinical teams, digital tutorials and quick reference guides for fast integration, and ongoing technical service and support to ensure long-term reliability.
For more information, visit https://www.hpaust.com
Source: Hospital Products Australia
Filed Under: Health
0 Comments
Latest on Aussie Journal
- Sober.Buzz Adds Second Podcast, "Spreading the Good BUZZ" Guest List Grows, Numbers Continue Growing Globally, All While Josh and Heidi Tied the Knot
- Council and Community Unite for Inline Hockey - Rec Board Faces Growing Pressure
- Bookmakers Review: Joe Rogan Favored to Win Inaugural 2025 Golden Globes Podcast of the Year
- Dr. Friedberg & Associates Brings Life-Changing All-on-4 Dental Implants and Comprehensive Smile Solutions to Houston
- JCOM1939 Monitor Software Simplifies SAE J1939 Data Monitoring with USB & Bluetooth Gateways
- Slotozilla Debuts "Casino Games as Superheroes" — A Bold Interactive Experience That Combines Gaming, Storytelling, and Visual Design
- Modernizing Pole Data Collection for Next-Gen Network Expansion
- Assent Joins AWS ISV Accelerate Program
- FreeTo.Chat Launches Silent Confessions, the Best Confession Site for Anonymous, Ad-Free Truth Sharing
- The Journey of a Soulful R&B Artist JNash
- Stop Scrolling, Start Thriving: Nova 3 Digital Powers Perth Businesses Online!
- The Link Between Environment and Emotional Development in Children
- Dr. Sanju P. Jose Highlights Expertise in Periodontics and Implant Dentistry
- Contracting Resources Group Appears Again on the Inc. List of Fastest-Growing Companies
- Phinge®, Home of Netverse® and Netaverse™ With Verified and Safer AI Announces "Test the Waters" Campaign for Potential Regulation A+ Offering
- Sustainably Made in New York: MOO Vodka and Cayuga Clear Expand Statewide Distribution
- $3 Billion Suicidal Depression Market Advancements on Multiple Fronts, Highlighted by FDA Fast Track Designation for Effective NRX 100 Drug Therapy
- What Can You Really Claim Without Receipts? Clear Tax Explains What's Allowed This Tax Season
- Cycurion Inc. N A S D A Q: CYCU Secures $89 Million in Contracts, New $20 Million Cyber Protection Tech Deal & Strategic Expansion into Cryptocurrency
- CCHR Addresses UN Committee on Support for Global End to Coercive Psychiatry